-
address the limitations of existing vaccines, we focus on: structure-based antigen design – identifying and engineering key viral antigens to elicit cross-protective immune responses; viral vector
-
to overseeing multiple (PhD) projects and providing biological insights or hypotheses to drive research progress and completion. ~50% will involve performing experiments or analyses. ~20% will be allocated
-
professors and 40 PhD students. We present the history of our planet, and the diversity of life on Earth, through permanent and temporary museum exhibitions, educational programmes, and online presence, with
-
. The group comprises PhD-students and technicians all working on different aspects of complement regulation on human cells, employing techniques like ELISA, flow cytometry, confocal imaging, recombinant
-
consists of interns, residents and PhD candidates. Together we are responsible for the education of veterinary students, provision of clinical services to horses and companion animals, and both clinical and
-
they can be linked to functional processes. Profile We are looking for an enthusiastic and highly motivated postdoc with prior PhD experience in computational genomics, ideally with experience in
-
universities, research institutes, industry, and government. We host over 120 researchers, including 15 academia-embedded professors, 30 postdocs, and 50 PhD students. We present the history of our planet and
-
for the faster translation of novel treatment strategies into early phase clinical trials. Your role will be to investigate novel immunotherapy strategies using genetically engineered immune cells in various
-
interested in this position, but do you first have some questions? Feel free to reach out to Jørgen de Jonge, PhD | RIVM , Department Head of Immune Mechanisms - Immunological Models (IIM), via +31 6 311 423
-
interested in this position, but do you first have some questions? Feel free to reach out to Jørgen de Jonge, PhD | RIVM , Department Head of Immune Mechanisms - Immunological Models (IIM), via +31 6 311 423